Overview

The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the relationship between two types of cell signals, type I interferon (IFN) and tumor necrosis factor (TNF), in psoriatic skin prior to and during treatment with etanercept and correlate that information with the degree of the improvement in the psoriasis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Michigan
Collaborator:
Amgen
Treatments:
Etanercept